These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 30091530)

  • 41. Activity of suberoylanilide hydroxamic Acid against human breast cancer cells with amplification of her-2.
    Bali P; Pranpat M; Swaby R; Fiskus W; Yamaguchi H; Balasis M; Rocha K; Wang HG; Richon V; Bhalla K
    Clin Cancer Res; 2005 Sep; 11(17):6382-9. PubMed ID: 16144943
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The miR-193a-3p-regulated ING5 gene activates the DNA damage response pathway and inhibits multi-chemoresistance in bladder cancer.
    Li Y; Deng H; Lv L; Zhang C; Qian L; Xiao J; Zhao W; Liu Q; Zhang D; Wang Y; Yan J; Zhang H; He Y; Zhu J
    Oncotarget; 2015 Apr; 6(12):10195-206. PubMed ID: 25991669
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined inhibition of EZH2 and histone deacetylases as a potential epigenetic therapy for non-small-cell lung cancer cells.
    Takashina T; Kinoshita I; Kikuchi J; Shimizu Y; Sakakibara-Konishi J; Oizumi S; Nishimura M; Dosaka-Akita H
    Cancer Sci; 2016 Jul; 107(7):955-62. PubMed ID: 27116120
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Histone deacetylase inhibitors SAHA and sodium butyrate block G1-to-S cell cycle progression in neurosphere formation by adult subventricular cells.
    Zhou Q; Dalgard CL; Wynder C; Doughty ML
    BMC Neurosci; 2011 May; 12():50. PubMed ID: 21615950
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histone deacetylase inhibitor attenuates experimental fungal keratitis in mice.
    Li X; Yuan M; Yin R; Liu X; Zhang Y; Sun S; Han L; He S
    Sci Rep; 2019 Jul; 9(1):9859. PubMed ID: 31285488
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel harmine derivative, N-(4-(hydroxycarbamoyl)benzyl)-1-(4- methoxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxamide (HBC), as histone deacetylase inhibitor: in vitro antiproliferation, apoptosis induction, cell cycle arrest, and antimetastatic effects.
    Miao JF; Peng YF; Chen S; Gao WJ; Yang QX; Zhu P; Guo J; Tao J; Luo L; Zhang Y; Ling Y
    Eur J Pharmacol; 2018 Apr; 824():78-88. PubMed ID: 29428472
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synergistic Effect of Epigenetic Inhibitors Decitabine and Suberoylanilide Hydroxamic Acid on Colorectal Cancer In vitro.
    Abou Najem S; Khawaja G; Hodroj MH; Rizk S
    Curr Mol Pharmacol; 2019; 12(4):281-300. PubMed ID: 30868973
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synergistic antineoplastic effect of DLC1 tumor suppressor protein and histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), on prostate and liver cancer cells: perspectives for therapeutics.
    Zhou X; Yang XY; Popescu NC
    Int J Oncol; 2010 Apr; 36(4):999-1005. PubMed ID: 20198346
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential Mechanisms of Cell Death Induced by HDAC Inhibitor SAHA and MDM2 Inhibitor RG7388 in MCF-7 Cells.
    Natarajan U; Venkatesan T; Radhakrishnan V; Samuel S; Rathinavelu A
    Cells; 2018 Dec; 8(1):. PubMed ID: 30583560
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synergistic Combination of Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid and Natural Flavonoid Curcumin Exhibits Anticancer and Antibacterial Activity.
    Altundağ EM; Toprak K; Şanlıtürk G; Güran M; Özbilenler C; Kerküklü NR; Yılmaz AM; Yalçın AS
    Anticancer Agents Med Chem; 2021; 21(10):1301-1308. PubMed ID: 33023457
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting histones for degradation in cancer cells as a novel strategy in cancer treatment.
    Yin Y; Zhu Q; Jiang T; Fan L; Qiu X
    Sci China Life Sci; 2019 Aug; 62(8):1078-1086. PubMed ID: 30465232
    [TBL] [Abstract][Full Text] [Related]  

  • 52. BRD4 inhibitor and histone deacetylase inhibitor synergistically inhibit the proliferation of gallbladder cancer in vitro and in vivo.
    Liu S; Li F; Pan L; Yang Z; Shu Y; Lv W; Dong P; Gong W
    Cancer Sci; 2019 Aug; 110(8):2493-2506. PubMed ID: 31215139
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-tumor effects of the histone deacetylase inhibitor vorinostat on canine urothelial carcinoma cells.
    Eto S; Saeki K; Yoshitake R; Yoshimoto S; Shinada M; Ikeda N; Kamoto S; Tanaka Y; Kato D; Maeda S; Tsuboi M; Chambers J; Uchida K; Nishimura R; Nakagawa T
    PLoS One; 2019; 14(6):e0218382. PubMed ID: 31206526
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Histone deacetylase inhibitor suberoylanilide hydroxamic acid alleviates liver fibrosis by suppressing the transforming growth factor-β1 signal pathway.
    Wang Y; Zhao L; Jiao FZ; Zhang WB; Chen Q; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):423-429. PubMed ID: 30249543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Histone deacetylase inhibitor induces cell apoptosis and cycle arrest in lung cancer cells via mitochondrial injury and p53 up-acetylation.
    Bao L; Diao H; Dong N; Su X; Wang B; Mo Q; Yu H; Wang X; Chen C
    Cell Biol Toxicol; 2016 Dec; 32(6):469-482. PubMed ID: 27423454
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Suberoylanilide hydroxamic acid (SAHA) combined with bortezomib inhibits renal cancer growth by enhancing histone acetylation and protein ubiquitination synergistically.
    Sato A; Asano T; Ito K; Sumitomo M; Asano T
    BJU Int; 2012 Apr; 109(8):1258-68. PubMed ID: 21895936
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dual targeting of histone deacetylases and MYC as potential treatment strategy for H3-K27M pediatric gliomas.
    Algranati D; Oren R; Dassa B; Fellus-Alyagor L; Plotnikov A; Barr H; Harmelin A; London N; Ron G; Furth N; Shema E
    Elife; 2024 Aug; 13():. PubMed ID: 39093942
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bortezomib and SAHA synergistically induce ROS-driven caspase-dependent apoptosis of nasopharyngeal carcinoma and block replication of Epstein-Barr virus.
    Hui KF; Lam BH; Ho DN; Tsao SW; Chiang AK
    Mol Cancer Ther; 2013 May; 12(5):747-58. PubMed ID: 23475956
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The mechanism of action of the histone deacetylase inhibitor vorinostat involves interaction with the insulin-like growth factor signaling pathway.
    Sarfstein R; Bruchim I; Fishman A; Werner H
    PLoS One; 2011; 6(9):e24468. PubMed ID: 21931726
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ING5 activity in self-renewal of glioblastoma stem cells via calcium and follicle stimulating hormone pathways.
    Wang F; Wang AY; Chesnelong C; Yang Y; Nabbi A; Thalappilly S; Alekseev V; Riabowol K
    Oncogene; 2018 Jan; 37(3):286-301. PubMed ID: 28925404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.